Mosquito-based malaria control through genetic, microbial and immunological innovations.

Genetic, microbial, and immunological innovations have the potential to revolutionize malaria control through sustainable, mosquito-targeted interventions.

• Why it matters: Malaria causes around 600,000 deaths annually, and existing insecticide and drug-based tools are increasingly ineffective due to resistance, behavioral adaptations, and logistical challenges, highlighting the urgent need for new strategies.
• What they did: The review synthesizes recent scientific advances in transgenic gene drives, engineered microorganisms, and transmission-blocking vaccines and drugs, while identifying knowledge gaps and safety considerations for their responsible use.
• The result: These innovations may enable the development of complementary, sustainable malaria control methods that can overcome current limitations and significantly impact global health efforts.